Evidence map›Paper›PMID 28900209›Full record

ArticleScientific reports2017

Iron oxide nanoparticles can cross plasma membranes.

Daniele Zanella, Elena Bossi, Rosalba Gornati, Carlos Bastos, Nuno Faria, Giovanni Bernardini

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. The "www" ofMembranes · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniele ZanellaDepartment of Biotechnology and Life Sciences, University of Insubria; Via Dunant 3, I-21100, Varese, Italy.
Elena BossiDepartment of Biotechnology and Life Sciences, University of Insubria; Via Dunant 3, I-21100, Varese, Italy. elena.bossi@uninsubria.it.ORCID 0000-0002-9549-2153
Rosalba GornatiDepartment of Biotechnology and Life Sciences, University of Insubria; Via Dunant 3, I-21100, Varese, Italy.
Carlos BastosDepartment of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 OES, UK.
Nuno FariaDepartment of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 OES, UK.
Giovanni BernardiniDepartment of Biotechnology and Life Sciences, University of Insubria; Via Dunant 3, I-21100, Varese, Italy.

Funding

Medical Research Council MC_U105960399
6 · The paper itself

Abstract

Iron deficiency is a major global public health problem despite decades of efforts with iron supplementation and fortification. The issue lies on the poor tolerability of the standard of care soluble iron salts, leading to non-compliance and ineffective correction of iron-deficiency anaemia. Iron nanoformulations have been proposed to fortify food and feed to address these issues. Since it was just postulated that some nanoparticles (NPs) might cross the plasma membrane also by a non-endocytotic pathway gaining direct access to the cytoplasm, we have studied iron NP uptake under this perspective. To this aim, we have used a recently tested protocol that has proven to be capable of following the cytoplasmic changes of iron concentration dynamics and we have demonstrated that iron oxide NPs, but not zerovalent iron NPs nor iron oxide NPs that were surrounded by a protein corona, can cross plasma membranes. By electrophysiology, we have also shown that a small and transient increase of membrane conductance parallels NP crossing of plasma membrane.

Identifiers

PMID28900209
PMCPMC5595914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.